Skip to content
Biodatica
Start free

Centre Oscar Lambret

Angers

OncologyPhase II
Compare Sign in to watch

What changed

Study registered, no phase assigned: National Clinical-biological Prospective Cohort of Incident Cases of Aggressive Fibromatosis (ALTITUDES)

3mo agoTrial registeredMar 30, 2026Source filing (opens the source filing in a new tab)

Momentum

86no change

Momentum 86 out of 100, unchanged since the last recompute.

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Phase II

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Peer position

681 pre-ticker oncology companies at Phase II

Peer ranking — where this company sits among its stage-and-area peers by momentum, and how its runway compares to the peer median — is part of the Analyst tier.

Compare seats

A ranking of the same momentum figure the feed publishes, computed live against public-filing peers. It is a relative position, not a recommendation, and it is identical for every viewer.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Trial

    PHASE2 registered

    May 15, 2019

    Metastatic Soft Tissue Sarcoma · COMPLETED · sponsor: Centre Oscar Lambret · Phase II Study of Regorafenib as Maintenance Therapy

    ClinicalTrials.gov · NCT03793361 (opens the source filing in a new tab)

  2. Trial

    NA registered

    Mar 22, 2016

    Aggressive Fibromatosis · ACTIVE_NOT_RECRUITING · sponsor: Centre Oscar Lambret · National Clinical-biological Prospective Cohort of Incident Cases of Aggressive Fibromatosis (ALTITUDES)

    ClinicalTrials.gov · NCT02867033 (opens the source filing in a new tab)

  3. Trial

    PHASE2 registered

    Jun 5, 2013

    Sarcoma · COMPLETED · sponsor: Centre Oscar Lambret · Phase II Study of Regorafenib in Metastatic Soft Tissue Sarcoma

    ClinicalTrials.gov · NCT01900743 (opens the source filing in a new tab)

  4. Trial

    PHASE2 registered

    Sep 10, 2010

    Angiosarcoma · COMPLETED · sponsor: Centre Oscar Lambret · Efficacity of Weekly Paclitaxel in Association or Not With Bevacizumab in Metastatic or Locally Advanced Angiosarcomas

    ClinicalTrials.gov · NCT01303497 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources